WHO ICTRP trial
Preventing the bone marrow graft from attacking the host's organs by injection…
EUCTR2012-000301-71-BE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2012-000301-71-BE |
|---|---|
| Public title | Preventing the bone marrow graft from attacking the host's organs by injection of regulatory cells. |
| Scientific title | Donor Regulatory T cells (Treg) infusion (DTI) in patients with steroid-refractory chronic graft-versus-host disease (GVHD). |
| Primary sponsor | CHU-ULg |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Belgium |
| Conditions | Steroid-refractory chronic graft-versus-host-disease. MedDRA version: 16.1 Level: PT Classification code 10066261 Term: Chronic graft versus host disease System Organ Class: 10021428 - Immune system disorders ;Therapeutic area: Body… |
| Interventions | Product Name: regulatory T cells Product Code: Treg Pharmaceutical Form: Infusion Trade Name: Rapamune Pharmaceutical Form: Tablet INN or Proposed INN: SIROLIMUS CAS Number: 53123-88-9 Other descriptive name: Rapamycin Concentration unit… |
| Registration date | Jun 12, 2012 |
| Target size | 35 |
| Secondary IDs | TJB1117P1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: